Pfizer Asserts 2nd Lyrica Patent Against Mylan
The pharmaceutical giant filed suit Friday in the U.S. District Court for the District of Delaware, where the parties are already litigating the defendants' efforts to introduce the generic. The new suit brings claims over a different patent.
According to the complaint, Alphapharm and Mylan have infringed U.S. Patent Number 6,197,819, titled...
To view the full article, register now.